Idorsia: Failure in Phase IIIBad news for Swiss drug discovery company Idorsia: Its Fabry disease hopeful lucerastat failed to reduce neuropathic pain in patients. more ➔
Delivering on Europe´s Green Deal –... Leading industry leaders, SMEs representatives and academia are joining in Vienna, Austria, at the 14th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB), from 6th to 7th of October, … more ➔
COVID-19 immunisation set to get FDA EUAPharma giant AstraZeneca has submitted data to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its antibody duo AZD7442. more ➔
Thermo Fisher opens Swiss biologics manufa...Lengnau will become the newest site in Thermo Fisher Scientifics biologics manufacturing network. The site is to be completed in 2022 and its staff of 200 will join the company. more ➔
BioNTech investigates cancer vaccine BNT12...BionTech SE, which has been very successful in the field of corona vaccines, is starting phase II tests with its colorectal cancer candidate BNT122. more ➔
Advent France Biotechnology launches €8...Advent France Biotechnologys has launched a second biotech seed fund with a first close at €86m. Since 2017, the French state fund has financed 15 startups in France, Spain, Belgium and Ireland with … more ➔
UK clears the way for gene-edited cropsPost-Brexit, UK ditches the strict EU regulation for genetic engineering: in future, gene-edited crops will be assessed just like any other new variety, the government said. more ➔
Team identifies factors for COVID-19 vacci...A comparison of immune correlates of AstraZeneca’s Phase II/III COVID-19 vaccine trial shows what antibodiy titer is required to prevent symptomatic disease. more ➔
AstraZeneca invests in saRNA platformAstraZeneca has teamed up with RNA vaccine and therapeutic developer VaxEquity, investing US$195m in milestone payments alone. more ➔
EIF supports translational med with €25mThe EIF has invested €25m in the Prague-based i&i Biotech Fund I to boost biomedical tech transfer in Austria and Eastern Europe. more ➔
